The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
novavax | 301 |
isconova | 37 |
novavax inc. (us) | 1 |
novavaks | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
functional influenza virus-like particles (vlps) | 56 | 2003 |
modified rsv f proteins and methods of their use | 51 | 2008 |
rabies glycoprotein virus-like particles (vlps) | 37 | 2010 |
varicella zoster virus-virus like particles (vlps) and antigens | 28 | 2007 |
functional influenza virus like particles (vlps) | 26 | 2005 |
influenza vaccine | 23 | 2010 |
recombinant nanoparticle rsv f vaccine for respiratory syncytial virus | 21 | 2011 |
quil a fraction with low toxicity and use thereof | 14 | 2003 |
vaccine compositions having improved stability and immunogenicity | 14 | 2015 |
composition comprising iscom particles and live micro-organisms | 13 | 2003 |